Ron H N van Schaik

发表

UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients.

H. McLeod, S. Houterman, H. Gelderblom, 2022, European journal of cancer.

C. Di Resta, J. Marc, Tuebingen, 2005 .

Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe

I. Brandslund, G. Siest, C. Di Resta, 2015, Drug metabolism and personalized therapy.

Review - The impact of pharmacogenetics on the outcome of immune checkpoint inhibitors.

S. Bins, A. V. D. van der Veldt, K. de Joode, 2023, Cancer treatment reviews.

Model‐Based Prediction of Irinotecan‐Induced Grade 4 Neutropenia in Cancer Patients: Influence of Incorporating Germline Genetic Factors in the Model

S. Karas, Ron H N van Schaik, Federico Innocenti, 2024, Clinical pharmacology and therapeutics.

Nonlinear Mixed-Effects Model of Z-Endoxifen Concentrations in Tamoxifen-Treated Patients from the CEPAM Cohort.

H. Brauch, J. Swen, M. White-Koning, 2024, Clinical pharmacology and therapeutics.

TGF-β mRNA levels in circulating extracellular vesicles are associated with response to anti-PD1 treatment in metastatic melanoma

S. Fogli, D. Cioni, F. Cucchiara, 2024, Frontiers in molecular biosciences.

Periconceptional Non-medical Maternal Determinants Influence the Tryptophan Metabolism: The Rotterdam Periconceptional Cohort (Predict Study)

S. V. van Zundert, Ron H N van Schaik, L. van Rossem, 2024, International journal of tryptophan research : IJTR.

A common germline variant in CYP11B1 is associated with adverse clinical outcome of treatment with abiraterone or enzalutamide.

R. Mathijssen, S. Koolen, S. Buck, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants

K. D. Sørensen, Jacob M. Keaton, R. Mägi, 2023, Nature Genetics.

Discovering novel germline genetic variants linked to severe fluoropyrimidine-related toxicity in- and outside DPYD

J. Swen, M. van der Lee, L. M. Henricks, 2024, Genome medicine.

External Quality Assessment on Molecular Tumor Profiling with Circulating Tumor DNA-Based Methodologies Routinely Used in Clinical Pathology within the COIN Consortium.

C. V. van Noesel, D. van den Broek, H. Dubbink, 2024, Clinical chemistry.